The prescription drug market is evolving rapidly, driven by the introduction of innovative therapies and significant legislative and regulatory activity. These changes are reshaping how pharmacy benefits are priced, managed, and delivered.

We recognize the challenges associated with managing rising costs in today’s economic environment. As prices continue to rise across everyday essentials — from groceries to fuel — health care, like many necessary services, is also impacted.

Across today’s pharmacy landscape, new drug indications, evolving formulations, and expanding patient populations are driving rapid growth in utilization—and accelerating spend for businesses. Therapies like GLP1s for metabolic conditions, oncology immunotherapies, and specialty biologics continue to broaden their reach, introducing rising costs and greater budget uncertainty.